These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 22202066)

  • 1. New applications of old metal-binding drugs in the treatment of human cancer.
    Schmitt SM; Frezza M; Dou QP
    Front Biosci (Schol Ed); 2012 Jan; 4(1):375-91. PubMed ID: 22202066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel metals and metal complexes as platforms for cancer therapy.
    Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP
    Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal Complexes in Cancer Treatment: Journey So Far.
    Kumar Singh A; Kumar A; Singh H; Sonawane P; Pathak P; Grishina M; Pal Yadav J; Verma A; Kumar P
    Chem Biodivers; 2023 Apr; 20(4):e202300061. PubMed ID: 36824028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
    Zhang Z; Wang H; Yan M; Wang H; Zhang C
    Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal Complexes or Chelators with ROS Regulation Capacity: Promising Candidates for Cancer Treatment.
    Li X; Wang Y; Li M; Wang H; Dong X
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.
    Abid M; Shamsi F; Azam A
    Mini Rev Med Chem; 2016; 16(10):772-86. PubMed ID: 26423699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
    Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Metal Homeostasis for Cancer Therapy.
    Yang Y; Fan H; Guo Z
    Chempluschem; 2024 Jun; 89(6):e202300624. PubMed ID: 38315756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent development of transition metal complexes with in vivo antitumor activity.
    Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
    J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-Target Metal-Based Anticancer Agents.
    Chen ZF; Orvig C; Liang H
    Curr Top Med Chem; 2017 Nov; 17(28):3131-3145. PubMed ID: 28982336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms.
    Njenga LW; Mbugua SN; Odhiambo RA; Onani MO
    Dalton Trans; 2023 May; 52(18):5823-5847. PubMed ID: 37021641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallo-Drugs in Cancer Therapy: Past, Present and Future.
    Lucaciu RL; Hangan AC; Sevastre B; Oprean LS
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-containing drugs and novel coordination complexes in therapeutic anticancer applications--part II.
    Kostova I
    Anticancer Agents Med Chem; 2010 Jun; 10(5):352-3. PubMed ID: 20545617
    [No Abstract]   [Full Text] [Related]  

  • 16. Copper and Copper Complexes in Tumor Therapy.
    Wang Y; Tang T; Yuan Y; Li N; Wang X; Guan J
    ChemMedChem; 2024 Jun; 19(11):e202400060. PubMed ID: 38443744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer metallotherapeutics in preclinical development.
    Kaluderović GN; Paschke R
    Curr Med Chem; 2011; 18(31):4738-52. PubMed ID: 21919843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noble metal-dithiocarbamates precious allies in the fight against cancer.
    Nagy EM; Ronconi L; Nardon C; Fregona D
    Mini Rev Med Chem; 2012 Oct; 12(12):1216-29. PubMed ID: 22931593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy.
    Li ZY; Shen QH; Mao ZW; Tan CP
    Chem Asian J; 2022 Jul; 17(13):e202200270. PubMed ID: 35419865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID-Based Coordination Compounds for Biomedical Applications: Recent Advances and Developments.
    Santos ACF; Monteiro LPG; Gomes ACC; Martel F; Santos TM; Ferreira BJML
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.